Given the inflammatory component of PCOS, altered CCL22 levels could influence the balance between pro-inflammatory and anti-inflammatory immune responses, potentially exacerbating the chronic low-grade inflammation observed in PCOS patients. The gene discussed is CCL22; the disease is polycystic ovary syndrome.